Multiple guidelines exist for the diagnosis and management of heart failure with preserved
ejection fraction (HFpEF). We systematically reviewed current guidelines and …

Diagnosis of heart failure with preserved ejection fraction (HFpEF) may be challenging
owing to the heterogeneous clinical presentation and comorbidities in this population of …

Heart failure with preserved ejection fraction (HFpEF) is a common clinical syndrome
associated with high rates of morbidity and mortality. Due to the lack of evidence-based …

Heart failure with preserved ejection fraction (HFpEF) represents a heterogeneous collection
of conditions that are unified by the presence of a left ventricular ejection fraction≥ 50 …

Background Clinical management of heart failure with preserved ejection fraction (HFpEF)
centres on treating comorbidities and is likely to vary between countries. Thus, to provide …

Heart failure with preserved ejection fraction (HFpEF) is a growing epidemiologic problem
affecting more than half of the patients with heart failure (HF). HFpEF has a significant …

Background Heart failure with preserved ejection fraction (HFpEF) represents a major global
and economic burden, but its epidemiological, clinical, and outcome data have varied …

Epidemiologic studies have shown that approximately half of patients with heart failure (HF)
have normal or near normal ejection fraction (EF); this syndrome is referred to as HF with …

Heart failure with preserved ejection fraction (HFPEF) is common and represents a major
challenge in cardiovascular medicine. Most of the current treatment of HFPEF is based on …

The aetiology of heart failure with preserved ejection fraction (HFpEF) is heterogenous and
overlaps with that of several comorbidities like atrial fibrillation, diabetes mellitus, chronic …